Results for tag: "Allogeneic Cell Therapy"

Allogeneic cell therapy is a type of genomics-based therapy that uses cells from a donor to treat a patient. It is a form of immunotherapy that uses cells from a healthy donor to stimulate the patient's immune system to fight disease. Allogeneic cell therapy is used to treat a variety of conditions, including cancer, autoimmune diseases, and genetic disorders. It is also being explored as a potential treatment for neurological disorders. Allogeneic cell therapy is a rapidly growing field, with many companies developing new treatments and technologies. Examples of companies in the allogeneic cell therapy market include Kite Pharma, Juno Therapeutics, and Bellicum Pharmaceuticals. Other companies, such as Cellectis and Fate Therapeutics, are also researching and developing allogeneic cell therapies. Show Less Read more